| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | -26.9% |
| Cost of Revenue | $1.0M | -43.9% |
| Gross Profit | $1.1M | +1.2% |
| R&D Expense | $24.0M | +314.5% |
| SG&A Expense | $23.6M | +100.5% |
| Operating Income | -$69.4M | -286.3% |
| Interest Expense | $3.8M | +553.4% |
| Pre-tax Income | -$73.2M | -308.1% |
| Income Tax | -$2.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.8M | -27.0% |
| Accounts Receivable | $104K | -91.4% |
| Inventory | $2.2M | +84.4% |
| Current Assets | $35.8M | -19.8% |
| Total Assets | $97.9M | -16.6% |
| Current Liabilities | $21.6M | +367.2% |
| Total Liabilities | $39.7M | +663.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.0M | -124.7% |
| Capital Expenditures | $2.9M | +211.9% |
| Investing Cash Flow | -$6.9M | +32.1% |
| Financing Cash Flow | $33.9M | -19.1% |
| Free Cash Flow | -$40.8M | -129.2% |
| +0.0% |
| Net Income | -$73.2M | -387.5% |
| EPS (Basic) | -$1.73 | -293.2% |
| EPS (Diluted) | -$1.73 | -293.2% |
| Stockholders' Equity |
| $58.2M |
| -48.1% |